Dierig, A.; Hoelscher, M.; Schultz, S.; Hoffmann, L.; Jarchow-MacDonald, A.; Svensson, E. M.; Te Brake, L.; Aarnoutse, R.; Boeree, M.; McHugh, T. D.; Wildner, L. M.; Gong, X.; Phillips, P. P. J.; Minja, L. T.; Ntinginya, N.; Mpagama, S.; Liyoyo, A.; Wallis, R. S.; Sebe, M.; Mhimbira, F. A.; Mbeya, B.; Rassool, M.; Geiter, L.; Cho, Y. L.; Heinrich, N. (2023): A phase IIb, open-label, randomized controlled dose ranging multi-centre trial to evaluate the safety, tolerability, pharmacokinetics and exposure-response relationship of different doses of delpazolid in combination with bedaquiline delamanid moxifloxacin in adult subjects with newly diagnosed, uncomplicated, smear-positive, drug-sensitive pulmonary tuberculosis. Trials, 24 (1). ISSN 1745-6215